- Home
- APLS vs ASAN Comparison
APLS vs ASAN Comparison
Compare APLS & ASAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- ASAN
- Stock Information
- Founded
- APLS 2009
- ASAN 2008
- Country
- APLS United States
- ASAN United States
- Employees
- APLS N/A
- ASAN N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- ASAN Retail: Computer Software & Peripheral Equipment
- Sector
- APLS Health Care
- ASAN Technology
- Exchange
- APLS Nasdaq
- ASAN Nasdaq
- Market Cap
- APLS 3.5B
- ASAN 3.1B
- IPO Year
- APLS 2017
- ASAN 2020
- Fundamental
- Price
- APLS $27.97
- ASAN $14.47
- Analyst Decision
- APLS Buy
- ASAN Hold
- Analyst Count
- APLS 20
- ASAN 16
- Target Price
- APLS $34.11
- ASAN $16.70
- AVG Volume (30 Days)
- APLS 3.0M
- ASAN 3.6M
- Earning Date
- APLS 07-31-2025
- ASAN 09-03-2025
- Dividend Yield
- APLS N/A
- ASAN N/A
- EPS Growth
- APLS N/A
- ASAN N/A
- EPS
- APLS N/A
- ASAN N/A
- Revenue
- APLS $754,649,000.00
- ASAN $738,695,000.00
- Revenue This Year
- APLS $10.84
- ASAN $10.25
- Revenue Next Year
- APLS $10.51
- ASAN $8.92
- P/E Ratio
- APLS N/A
- ASAN N/A
- Revenue Growth
- APLS 20.02
- ASAN 9.84
- 52 Week Low
- APLS $16.10
- ASAN $11.05
- 52 Week High
- APLS $41.94
- ASAN $27.77
- Technical
- Relative Strength Index (RSI)
- APLS 74.59
- ASAN 53.92
- Support Level
- APLS $26.23
- ASAN $13.24
- Resistance Level
- APLS $28.87
- ASAN $14.29
- Average True Range (ATR)
- APLS 1.07
- ASAN 0.58
- MACD
- APLS 0.18
- ASAN 0.04
- Stochastic Oscillator
- APLS 84.04
- ASAN 81.11
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About ASAN Asana Inc.
Asana is a provider of collaborative work management software delivered via a cloud-based SaaS model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases, including marketing programs, managing IT approvals, and performance management. Asana's offering supports workflow management across teams, provides real time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per seat basis.